Viewing Study NCT05468359


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-02-02 @ 1:39 AM
Study NCT ID: NCT05468359
Status: SUSPENDED
Last Update Posted: 2025-05-25
First Post: 2022-06-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Sponsor:
Organization: